Share Email Print
cover

Proceedings Paper

Rapid one-step assay for prostate specific antigen in whole blood using an optical immunoassay technology
Author(s): Grenville Robinson; Timothy Bacarese-Hamilton; Paul M. O'Neill; Janys E. Fletcher; Phelim B. Daniels; Christopher G. Stafford
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Much interest has been shown in the development of rapid, one step immunoassay systems for the point-of-care market. The fluorescence capillary fill device (FCFD) is a technology that fulfills the requirements for a system to penetrate this market. The performance of the FCFD is demonstrated in an assay for prostate specific antigen (PSA) in whole blood, the FCFD assay has adequate analytical (a detection limit of less than 0.4 ng/mL PSA and reasonable precision over the clinically relevant range of the assay) and clinical performance (good correlations with commercial PSA assays).

Paper Details

Date Published: 10 February 1995
PDF: 8 pages
Proc. SPIE 2331, Medical Sensors II and Fiber Optic Sensors, (10 February 1995); doi: 10.1117/12.201248
Show Author Affiliations
Grenville Robinson, SCL Bioscience Services Ltd. (United Kingdom)
Timothy Bacarese-Hamilton, SCL Bioscience Services Ltd. (United Kingdom)
Paul M. O'Neill, SCL Bioscience Services Ltd. (United Kingdom)
Janys E. Fletcher, SCL Bioscience Services Ltd. (United Kingdom)
Phelim B. Daniels, SCL Bioscience Services Ltd. (United Kingdom)
Christopher G. Stafford, SCL Bioscience Services Ltd. (United Kingdom)


Published in SPIE Proceedings Vol. 2331:
Medical Sensors II and Fiber Optic Sensors
Anna Maria Verga Scheggi; Francesco Baldini; Pierre R. Coulet; Otto S. Wolfbeis, Editor(s)

© SPIE. Terms of Use
Back to Top